Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

SCNISCNI
5 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in SCINAI IMMUNOTHERAPEUTICS LT

CITADEL ADVISORS LLC holds 62,257 shares of SCNI (SCINAI IMMUNOTHERAPEUTICS LT), worth $15,726 as of 2026-Q2. This is a new position.

Current Value

$15,726

Current Shares

62,257

Total Value Change

-$10,836

Total Shares Change

+50,658

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
62,257
-
$15,7260.0%$0.25
28
2026-Q1
Exited
0
-100.0%
$00.0%$0.80
0
2025-Q4
Increased
34,562
+20.7%
$24,6120.0%$0.72
16
2025-Q3
Increased
28,630
+146.8%
$36,2170.0%$1.20
22
2025-Q2
New
11,599
-
$26,5620.0%$2.28
30

Other major holders of SCNI: UBS Group AG, BANK OF MONTREAL /CAN/, XTX Topco Ltd

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used